Impact of the preoperative des-gamma-carboxy prothrombin level on prognosis after hepatectomy for hepatocellular carcinoma meeting the Milan criteria

Surgery Today

Volumn 40, Issue 7, 2010, Pages 638-645

  Sakaguchi, Takanori ^a   Suzuki, Shohachi ^b   Morita, Yoshifumi ^a   Oishi, Kousuke ^a   Suzuki, Atsushi ^a   Fukumoto, Kazuhiko ^a   Inaba, Keisuke ^a   Nakamura, Satoshi ^a   Konno, Hiroyuki ^a  

^a HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^b Iwata City Hospital   (Japan)

Author keywords

Hepatectomy; Hepatocellular carcinoma; Liver transplantation; Milan criteria

Indexed keywords

DECARBOXYPROTHROMBIN; ALPHA FETOPROTEIN; BIOLOGICAL MARKER; PROTEIN PRECURSOR; PROTHROMBIN; TUMOR MARKER;

ADULT; AGED; ARTICLE; CANCER PATIENT; CONTROLLED STUDY; FEMALE; FOLLOW UP; HUMAN; LIVER CELL CARCINOMA; LIVER FUNCTION; LIVER RESECTION; LIVER TRANSPLANTATION; MAJOR CLINICAL STUDY; MALE; PATIENT SELECTION; POSTOPERATIVE COMPLICATION; PREDICTION; PREOPERATIVE EVALUATION; PROGNOSIS; PROPORTIONAL HAZARDS MODEL; RETROSPECTIVE STUDY; SURGICAL MORTALITY; SURVIVAL RATE; BLOOD; CARCINOMA, HEPATOCELLULAR; LIVER NEOPLASMS; MIDDLE AGED; MORTALITY; PREDICTIVE VALUE; PREOPERATIVE PERIOD; SURVIVAL;

AGED; ALPHA-FETOPROTEINS; BIOLOGICAL MARKERS; CARCINOMA, HEPATOCELLULAR; FEMALE; HEPATECTOMY; HUMANS; LIVER NEOPLASMS; LIVER TRANSPLANTATION; MALE; MIDDLE AGED; PATIENT SELECTION; PREDICTIVE VALUE OF TESTS; PREOPERATIVE PERIOD; PROGNOSIS; PROPORTIONAL HAZARDS MODELS; PROTEIN PRECURSORS; PROTHROMBIN; RETROSPECTIVE STUDIES; SURVIVAL ANALYSIS; TUMOR MARKERS, BIOLOGICAL;

EID: 77955646178     PISSN: 09411291     EISSN: 14362813     Source Type: Journal    
DOI: 10.1007/s00595-009-4109-3     Document Type: Article

References (20)

1. H.B. El-Serag A.C. Mason 1999 Rising incidence of hepatocellular carcinoma in the United States N Engl J Med 340 745 750 10.1056/ NEJM199903113401001 1:STN:280:DyaK1M7ls1ensg%3D%3D 10072408
2. A. Burroughs D. Hochhauser T. Meyer 2004 Systemic treatment and liver transplantation for hepatocellular carcinoma: Two ends of the therapeutic spectrum Lancet Oncol 5 409 418 10.1016/S1470-2045(04)01508-6 15231247
3. V. Mazzaferro E. Regalia R. Doci S. Andreola A. Pulvirenti F. Bozzetti, et al. 1996 Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis N Engl J Med 334 693 699 10.1056/NEJM199603143341104 1:STN:280:DyaK287nsFWltw%3D%3D 8594428
4. R.T. Poon 2007 Optimal initial treatment for early hepatocellular carcinoma in patients with preserved liver function: Transplantation or resection? Ann Surg Oncol 14 541 547 10.1245/s10434-006-9156-z 17103069
5. S. Eguchi M. Takatsuki M. Hidaka Y. Tajima T. Kanematsu 2008 Evolution of living donor liver transplantation over 10 years: Experience of a single center Surg Today 38 795 800 10.1007/s00595-007-3729-8 18751944
6. S. Tanaka N. Noguchi T. Ochiai A. Kudo N. Nakamura K. Ito, et al. 2007 Outcomes and recurrence of initially resectable hepatocellular carcinoma meeting Milan criteria: Rationale for partial hepatectomy as first strategy J Am Coll Surg 204 1 6 10.1016/j.jamcollsurg.2006.10.004 17189106
7. H. Imamura K. Sano Y. Sugawara N. Kokudo M. Makuuchi 2005 Assessment of hepatic reserve for indication of hepatic resection: decision tree incorporating indocyanine green test J Hepatobiliary Pancreat Surg 12 16 22 10.1007/s00534-004-0965-9 15754094
8. Couinaud C, Foie L. Etudes anatomiques et chirurgicales. Paris: Masson; 1957.
9. R.T. Poon S.T. Fan C.M. Lo C.L. Liu J. Wong 2007 Difference in tumor invasiveness in cirrhotic patients with hepatocellular carcinoma fulfilling the Milan criteria treated by resection and transplantation: Impact on long-term survival Ann Surg 245 51 58 10.1097/01.sla.0000225255.01668.65 17197965
10. C. Margarit A. Escartin L. Castells V. Vargas E. Allende I. Bilbao 2005 Resection for hepatocellular carcinoma is a good option in Child-Turcotte-Pugh class a patients with cirrhosis who are eligible for liver transplantation Liver Transpl 11 1242 1251 10.1002/lt.20398 16184539
11. T. Kamiyama K. Nakanishi H. Yokoo H. Kamachi M. Tahara T. Suzuki, et al. 2009 Recurrence patterns after hepatectomy of hepatocellular carcinoma: implication of Milan criteria utilization Ann Surg Oncol 16 1560 1571 10.1245/s10434-009-0407-7 19259739
12. J. Yamamoto T. Kosuge A. Saiura Y. Sakamoto K. Shimada T. Sano, et al. 2007 Effectiveness of hepatic resection for early-stage hepatocellular carcinoma in cirrhotic patients: subgroup analysis according to Milan criteria Jpn J Clin Oncol 37 287 295 10.1093/jjco/hym025 17553819
13. C. Zavaglia L. De Carlis A.B. Alberti E. Minola L.S. Belli A.O. Slim, et al. 2005 Predictors of long-term survival after liver transplantation for hepatocellular carcinoma Am J Gastroenterol 100 2708 2716 10.1111/j.1572-0241. 2005.00289.x 16393224
14. S. Ko H. Kanehiro M. Hisanaga M. Nagao N. Ikeda Y. Nakajima 2002 Liver fibrosis increases the risk of intrahepatic recurrence after hepatectomy for hepatocellular carcinoma Br J Surg 89 57 62 10.1046/j.0007-1323.2001.01969.x 1:STN:280:DC%2BD387hvVCnuw%3D%3D 11851664
15. H. Imamura Y. Matsuyama Y. Miyagawa K. Ishida R. Shimada S. Miyagawa, et al. 1999 Prognostic significance of anatomical resection and des-gamma-carboxy prothrombin in patients with hepatocellular carcinoma Br J Surg 86 1032 1038 10.1046/j.1365-2168.1999.01185.x 1:STN:280:DyaK1MzptVagsg%3D%3D 10460639
16. S. Fukuda T. Itamoto H. Nakahara T. Kohashi H. Ohdan H. Hino, et al. 2005 Clinicopathologic features and prognostic factors of resected solitary small-sized hepatocellular carcinoma Hepatogastroenterology 52 1163 1167 16001653
17. Y. Koike Y. Shiratori S. Sato S. Obi T. Teratani M. Imamura, et al. 2001 Des-gamma-carboxy prothrombin as a useful predisposing factor for the development of portal venous invasion in patients with hepatocellular carcinoma: a prospective analysis of 227 patients Cancer 91 561 569 10.1002/1097- 0142(20010201)91:3<561::AID-CNCR1035>3.0.CO;2-N 1:CAS:528: DC%2BD3MXhtVKjsLk%3D 11169939
18. H. Okuda T. Nakanishi K. Takatsu A. Saito N. Hayashi K. Takasaki, et al. 2000 Serum levels of des-gamma-carboxy prothrombin measured using the revised enzyme immunoassay kit with increased sensitivity in relation to clinicopathologic features of solitary hepatocellular carcinoma Cancer 88 544 549 10.1002/(SICI)1097-0142(20000201)88:3<544::AID-CNCR8>3.0.CO;2-F 1:CAS:528:DC%2BD3cXptVakuw%3D%3D 10649245
19. M. Sala J. Fuster J.M. Llovet M. Navasa M. Sole M. Varela, et al. 2004 High pathological risk of recurrence after surgical resection for hepatocellular carcinoma: an indication for salvage liver transplantation Liver Transpl 10 1294 1300 10.1002/lt.20202 15376311
20. H.H. Lee J.W. Joh J.H. Park K.W. Lee J.S. Heo S.H. Choi, et al. 2005 Microvascular tumor embolism: independent prognostic factor after liver transplantation in hepatocellular carcinoma Transplant Proc 37 1251 1253 10.1016/j.transproceed.2005.01.018 1:STN:280:DC%2BD2M3hsFShug%3D%3D 15848686